GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,556.00
Bid: 12,588.00
Ask: 12,590.00
Change: -34.00 (-0.27%)
Spread: 2.00 (0.016%)
Open: 12,626.00
High: 12,646.00
Low: 12,474.00
Prev. Close: 12,590.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

"Early warning signals" as testing demand rises for first time weeks

Thu, 18th Mar 2021 16:18

(Alliance News) - Community demand for coronavirus tests has increased by more than 9% in the last week, the first rise for five weeks, the Health & Safety Executive said.

HSE chief executive Paul Reid said the trend was an "early warning signal" that progress made in bringing down positive case numbers and hospital admissions is stalling.

Reid said there was "some concern" that the daily case numbers are no longer falling as they have been in recent weeks.

He told an HSE briefing on Thursday: "There are early warning signals for us that the brakes are being slightly put on in terms of improvements we've been making over the previous few weeks.

"Because the rate of decrease in hospitalisations for patients with Covid has slowed, particularly over the last few weeks, it's actually stalled.

"And the slowing in reduction of the hospitalised cases mirrors the slowing in reduction of the overall cases happening in the community."

He added: "Community testing demand has increased by over 9% in the past week, community demand for testing has increased for the first time in five weeks.

"That's just one of the early trends, early warning indicators I mentioned earlier on."

In terms of vaccinations however, Reid said the "glass is half full" despite problems with supply and the decision to pause administration of the AstraZeneca inoculation.

The European Medicines Agency is to decide on Thursday whether the AstraZeneca vaccine is safe after its use was paused by a number of European countries, including Ireland.

It followed reports by the Norwegian Medicines Agency of blood clots in a number of patients.

Reid said the decision to pause its use demonstrated the "huge emphasis that we will continuously put on safety of the population".

He added: "Just to reassure, we will respond quickly to whatever decision is recommended, and communicated onwards to us.

"Despite this disappointment we should, in my view, say the glass is half full.

"We have administered around 620,000 vaccinations, and we are witnessing, every day, the collapsing infection rates amongst residents in long-term care facilities, on health care workers and the oldest age groups in the population."

The HSE anticipates that between 70,000 and 75,000 vaccines will be administered next week in the over-70s population.

The health service has now carried out four million coronavirus tests and conducted one million close contact calls.

The seven days up to March 17 saw 3,646 new cases notified, an increase of 6% on the previous week.

Almost 46% of new cases over the past two weeks were among people aged 19 to 44 .

Some 26% of new cases in that period were among children aged 0 to 18 years, and about 8.6% were among people aged 65 years and over.

Reid said: "There are significant signs of stalling in the previously reported progress of cases.

"Numbers of new cases has slightly increased, the reductions in hospitalisations has certainly stalled last week. More positively, the numbers in ICU are reducing."

Over the last 14 days, of the 7,048 new cases notified between March 3 and 16, 6% of them (422) have been admitted to hospital.

Of those, 9% of them were in the age group 0 to 18, with no ICU admissions in that period.

Just over 19% were in the age group 19 to 34 with two ICU admissions.

Almost 33% were in the age group 35 to 64 with four ICU admissions, and around 29% were 65 and over, with seven ICU admissions.

Reid said: "Our hospitals still continue to have significant pressures in relation to Covid and management of Covid.

"We do hope that the progress we have seen in the past few weeks, picks up again in the coming couple of weeks."

On Wednesday, a further 17 deaths of people with coronavirus and another 557 confirmed cases of the virus were notified.

By James Ward, PA

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.